Literature DB >> 31104044

Insights into cognitive work hardening for return-to-work following depression: Qualitative findings from an intervention study.

Adeena Wisenthal1, Terry Krupa2, Bonnie Kirsh3, Rosemary Lysaght2.   

Abstract

BACKGROUND: Workplace mental health disability claims are rising with concomitant challenges to return-to-work (RTW) success. Cognitive work hardening (CWH) addresses work re-entry issues including fatigue, coping skills, and reduced cognitive abilities which are relevant for people returning to work following an episode of depression.
OBJECTIVE: To gain insight into underlying factors contributing to CWH's effectiveness in RTW preparation following depression.
METHODS: Twenty-one individuals on paid disability leave due to depression completed a four week CWH treatment intervention prior to returning to work. At program completion and at three months follow up, participants provided qualitative information regarding their experience of the intervention in the form of written questionnaires and interviews. Data were analyzed using a directed approach to content analysis.
RESULTS: Intervention elements perceived by participants as helpful included structure, work simulations, and simulated work environment. Main treatment gains reported by participants related to routine, self-confidence, stamina, and cognitive abilities. Personal agency, empowerment, and skill development emerged as important consequences of interventions for RTW following depression.
CONCLUSIONS: Study findings enhance understanding of CWH with relevance to clinical practice. Key intervention elements deemed important for RTW are discussed and may provide guidance for other work-re-entry programs.

Entities:  

Keywords:  Mental health; cognitive abilities; occupational therapy

Mesh:

Year:  2019        PMID: 31104044     DOI: 10.3233/WOR-192893

Source DB:  PubMed          Journal:  Work        ISSN: 1051-9815


  1 in total

1.  Case Report: Cognitive Work Hardening for Return-to-Work Following Depression.

Authors:  Adeena Wisenthal
Journal:  Front Psychiatry       Date:  2021-04-12       Impact factor: 4.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.